INTEGRATED BIOPHARMA REPORTS SECOND QUARTER RESULTS

Integrated BioPharma, Inc. INB reported financial results today for the three and six month periods ended December 31, 2005. Net income applicable to common shareholders for the quarter was $685,518, or $0.05 per diluted share, compared with a net loss of $3.3 million, or $(0.26) per diluted share, for the same period in 2004.
MSN Money